ANDA 83393, held by Valeant Pharmaceuticals International. Quinidine Sulfate.
As of Nov 21, 2026, ANDA 83393 (Quinidine Sulfate), held by Valeant Pharmaceuticals International, was first approved by FDA on Apr 29, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 29, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate200MG · tablet;oral | Quinidine Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters